Cargando…

Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors

The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET(∞)H(2)O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodaira, Satoshi, Kitamura, Hisashi, Kurano, Mieko, Kawashima, Hajime, Benton, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403338/
https://www.ncbi.nlm.nih.gov/pubmed/30842438
http://dx.doi.org/10.1038/s41598-019-39598-0
_version_ 1783400576379256832
author Kodaira, Satoshi
Kitamura, Hisashi
Kurano, Mieko
Kawashima, Hajime
Benton, Eric R.
author_facet Kodaira, Satoshi
Kitamura, Hisashi
Kurano, Mieko
Kawashima, Hajime
Benton, Eric R.
author_sort Kodaira, Satoshi
collection PubMed
description The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET(∞)H(2)O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were measured using CR-39 plastic nuclear track detectors and analyzed by means of atomic force microscopy. It was found that secondary target fragments contributed 20% to dose equivalent for primary protons (157 MeV), 13% for primary helium ions (145 MeV/n) and 4% for primary carbon ions (383 MeV/n), respectively. Little research has been done on the contribution from these particles to primary given dose. The smaller contribution measured for energetic carbon ion beams compared to proton beams can be considered an advantage of carbon ion radiotherapy over proton radiotherapy.
format Online
Article
Text
id pubmed-6403338
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64033382019-03-08 Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors Kodaira, Satoshi Kitamura, Hisashi Kurano, Mieko Kawashima, Hajime Benton, Eric R. Sci Rep Article The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET(∞)H(2)O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were measured using CR-39 plastic nuclear track detectors and analyzed by means of atomic force microscopy. It was found that secondary target fragments contributed 20% to dose equivalent for primary protons (157 MeV), 13% for primary helium ions (145 MeV/n) and 4% for primary carbon ions (383 MeV/n), respectively. Little research has been done on the contribution from these particles to primary given dose. The smaller contribution measured for energetic carbon ion beams compared to proton beams can be considered an advantage of carbon ion radiotherapy over proton radiotherapy. Nature Publishing Group UK 2019-03-06 /pmc/articles/PMC6403338/ /pubmed/30842438 http://dx.doi.org/10.1038/s41598-019-39598-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kodaira, Satoshi
Kitamura, Hisashi
Kurano, Mieko
Kawashima, Hajime
Benton, Eric R.
Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
title Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
title_full Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
title_fullStr Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
title_full_unstemmed Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
title_short Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
title_sort contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, he and c beams measured with cr-39 plastic nuclear track detectors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403338/
https://www.ncbi.nlm.nih.gov/pubmed/30842438
http://dx.doi.org/10.1038/s41598-019-39598-0
work_keys_str_mv AT kodairasatoshi contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors
AT kitamurahisashi contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors
AT kuranomieko contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors
AT kawashimahajime contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors
AT bentonericr contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors